Insights+: The US FDA New Drug Approvals in September 2023

Shots:The US FDA approved 7 NDAs and 2 BLAs in September 2023, leading to treatments for patients and advances in the healthcare industry. The CDER and CBER approved 98 novel products in 2023In September 2023, the major highlights drugs were Ojjaara (momelotinib) approval for myelofibrosis patients with anemia, and Entyvio (vedolizumab) for subcutaneous…

BySenior EditorOctober 18, 2023

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop itLife sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this diseasePharmaShots is keeping a track of all of the important updates in the Life-sciences…

BySenior EditorNovember 26, 2020

Insights+: The US FDA New Drug Approvals in September 2023

Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

Contact US

OUR INFORMATION

FOLLOW US